ABSTRACT
The article provides the summarized data of clinical trials evaluating the efficacy and safety of kagocel used to prevent and treat influenza and acute respiratory viral infections of different etiologies. The results of numerous preclinical and clinical trials suggest that the kagocel substance is highly safe and that it is appropriate to use the drug for the treatment and prevention of influenza and acute respiratory viral infections of another etiology.
Subject(s)
Antiviral Agents/pharmacology , Influenza, Human , Interferon Inducers/pharmacology , Respiratory Tract Infections , Virus Diseases , Clinical Trials as Topic , Drug Evaluation, Preclinical , Humans , Influenza, Human/prevention & control , Influenza, Human/therapy , Respiratory Tract Infections/prevention & control , Respiratory Tract Infections/therapy , Virus Diseases/prevention & control , Virus Diseases/therapyABSTRACT
This article is about the contribution of the Red Army Medical Service made in the process of combat casualty recovery of personnel of the active army in the years of the Great Patriotic war by returning wounded and sick to their ranks after their treatment. The authors show the main organizational measures which provided for creation of a casualty recovery system; describe the contents of information procedures for assuring the wounded and sick traffic control; emphasize the necessity to utilize the experience of the Red Army Medical Service for the development of the combat casualty recovery system in the Armed Forces in case of war.